FR2298832A1 - Procede de regulation de - Google Patents

Procede de regulation de

Info

Publication number
FR2298832A1
FR2298832A1 FR7601294A FR7601294A FR2298832A1 FR 2298832 A1 FR2298832 A1 FR 2298832A1 FR 7601294 A FR7601294 A FR 7601294A FR 7601294 A FR7601294 A FR 7601294A FR 2298832 A1 FR2298832 A1 FR 2298832A1
Authority
FR
France
Prior art keywords
regulation process
regulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7601294A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hospital for Sick Children HSC
Original Assignee
Hospital for Sick Children HSC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital for Sick Children HSC filed Critical Hospital for Sick Children HSC
Publication of FR2298832A1 publication Critical patent/FR2298832A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
    • A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Optics & Photonics (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR7601294A 1975-01-22 1976-01-19 Procede de regulation de Withdrawn FR2298832A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA218,410A CA1040271A (fr) 1975-01-22 1975-01-22 Cellule beta artificielle

Publications (1)

Publication Number Publication Date
FR2298832A1 true FR2298832A1 (fr) 1976-08-20

Family

ID=4102116

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7601294A Withdrawn FR2298832A1 (fr) 1975-01-22 1976-01-19 Procede de regulation de

Country Status (8)

Country Link
JP (1) JPS51125993A (fr)
AU (1) AU1032476A (fr)
CA (1) CA1040271A (fr)
DE (1) DE2601893A1 (fr)
FR (1) FR2298832A1 (fr)
GB (1) GB1498332A (fr)
IT (1) IT1053386B (fr)
SE (1) SE7600588L (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2409741A1 (fr) * 1977-11-25 1979-06-22 Miles Lab Appareil pour la surveillance du glucose dans le sang
EP0027470A4 (fr) * 1979-04-30 1981-09-01 Lichtenstein Eric Stefan Systeme de soins medicaux controles par ordinateur.
EP0032927A4 (fr) * 1979-07-31 1982-05-10 Univ Rockefeller Systeme de liberation controlee de substances biologiquement actives dans un fluide d'un corps.
US4469681A (en) * 1979-07-31 1984-09-04 The Rockefeller University Method and system for the controlled release of biologically active substances to a body fluid
FR2557445A1 (fr) * 1984-01-02 1985-07-05 Katsch G Zent Inst Diabetes Procede et dispositif pour la determination automatique prospective de parametres individuellement specifiques de la regulation du glucose
WO1987003814A1 (fr) * 1985-12-20 1987-07-02 Schrezenmeir Juergen Dispositif d'administration continue ou discontinue d'insuline dans le corps humain

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2737922A1 (de) * 1977-08-23 1979-03-08 Fresenius Chem Pharm Ind Kuenstliche endokrine druese
JPS58198351A (ja) * 1982-05-15 1983-11-18 株式会社京都第一科学 希釈される体液中の特定成分を連続的に測定する装置
JPS598969A (ja) * 1982-07-09 1984-01-18 藤沢薬品工業株式会社 人工膵臓
FR2531333B1 (fr) * 1982-08-09 1986-04-04 Centre Nat Rech Scient Pancreas bio-artificiel a ultrafiltration
CA1254091A (fr) * 1984-09-28 1989-05-16 Vladimir Feingold Systeme implantable pour la perfusion de medicaments
GB8818690D0 (en) * 1988-08-05 1988-09-07 Red Kite Technology Ltd Refractive index measurement
US7037277B1 (en) 1998-07-21 2006-05-02 Spectrx, Inc. System and method for fluid management in a continuous fluid collection and sensor device
US7384396B2 (en) 1998-07-21 2008-06-10 Spectrx Inc. System and method for continuous analyte monitoring
AUPR632301A0 (en) * 2001-07-11 2001-08-02 Chee, Frederick Howe-Hui Infusion apparatus for regulating blood glucose levels
US7509156B2 (en) 2005-05-18 2009-03-24 Clarian Health Partners, Inc. System for managing glucose levels in patients with diabetes or hyperglycemia
US8417311B2 (en) 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
CA2702116C (fr) 2007-10-10 2021-01-05 Optiscan Biomedical Corporation Systeme d'analyse de composant de fluide et procede pour controler et reguler le glucose
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
CN111905188B (zh) 2015-02-18 2022-07-22 英赛罗公司 流体输送和输注装置及其使用方法
WO2017123525A1 (fr) 2016-01-13 2017-07-20 Bigfoot Biomedical, Inc. Interface utilisateur pour système de gestion du diabète
HK1256995A1 (zh) 2016-01-14 2019-10-11 Bigfoot Biomedical, Inc. 药物输送设备、系统和方法中的阻塞解决方案
US10806859B2 (en) 2016-01-14 2020-10-20 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
US10765807B2 (en) 2016-09-23 2020-09-08 Insulet Corporation Fluid delivery device with sensor
US11096624B2 (en) 2016-12-12 2021-08-24 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and systems
EP3568860B1 (fr) 2017-01-13 2025-12-10 Insulet Corporation Méthodes, systèmes et dispositifs d'administration d'insuline
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10881792B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US11033682B2 (en) 2017-01-13 2021-06-15 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
US11565043B2 (en) 2018-05-04 2023-01-31 Insulet Corporation Safety constraints for a control algorithm based drug delivery system
US12562251B1 (en) 2018-05-09 2026-02-24 Bigfoot Biomedical, Inc. Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices
AU2019347755B2 (en) 2018-09-28 2023-02-02 Insulet Corporation Activity mode for artificial pancreas system
EP3864668A1 (fr) 2018-10-11 2021-08-18 Insulet Corporation Détection d'événement pour système d'administration de médicament
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
EP4069082B1 (fr) 2019-12-06 2024-06-05 Insulet Corporation Techniques et dispositifs de fourniture d'adaptabilité et de personnalisation dans le traitement du diabète
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
JP7512395B2 (ja) 2020-01-06 2024-07-08 インスレット コーポレイション 持続する残差に基づく食事および／または運動行為の予測
EP4100958A1 (fr) 2020-02-03 2022-12-14 Insulet Corporation Utilisation d'une logique floue pour prédire un comportement d'utilisateur affectant la glycémie
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US12495994B2 (en) 2020-02-20 2025-12-16 Insulet Corporation Meal bolus subcategories in model based insulin therapy
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US12121700B2 (en) 2020-07-22 2024-10-22 Insulet Corporation Open-loop insulin delivery basal parameters based on insulin delivery records
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
US12569619B2 (en) 2020-09-21 2026-03-10 Insulet Corporation Techniques for determining automated insulin delivery dosages
EP4696344A3 (fr) 2020-09-30 2026-04-15 Insulet Corporation Dispositif d'administration de médicament à glucomètre optique intégré
US12115351B2 (en) 2020-09-30 2024-10-15 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
US11160925B1 (en) 2021-01-29 2021-11-02 Insulet Corporation Automatic drug delivery system for delivery of a GLP-1 therapeutic
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
EP4305636A1 (fr) 2021-03-10 2024-01-17 Insulet Corporation Dispositif d'administration de médicament ayant une composante de coût de niveau d'analyte réglable et par segments pour répondre aux écarts de niveau d'analyte positifs persistants
US12592306B2 (en) 2021-04-28 2026-03-31 Insulet Corporation Devices and methods for initialization of drug delivery devices using measured analyte sensor information
US12496398B2 (en) 2021-05-28 2025-12-16 Insulet Corporation Threshold based automatic glucose control response
EP4101482A1 (fr) 2021-06-07 2022-12-14 Insulet Corporation Prédiction de sécurité d'exercice basée sur les conditions physiologiques
US12514980B2 (en) 2021-06-30 2026-01-06 Insulet Corporation Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase
US12521486B2 (en) 2021-07-16 2026-01-13 Insulet Corporation Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems
WO2023049900A1 (fr) 2021-09-27 2023-03-30 Insulet Corporation Techniques permettant l'adaptation de paramètres dans des systèmes d'aide par entrée d'utilisateur
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
EP4243030A1 (fr) 2022-03-09 2023-09-13 Insulet Corporation Ajustement de paramètres d'administration de médicament dans un mode d'administration de médicament en boucle ouverte
EP4646726A1 (fr) 2023-01-06 2025-11-12 Insulet Corporation Administration de bolus de repas lancée automatiquement ou manuellement avec assouplissement automatique ultérieur des contraintes de sécurité

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2409741A1 (fr) * 1977-11-25 1979-06-22 Miles Lab Appareil pour la surveillance du glucose dans le sang
EP0027470A4 (fr) * 1979-04-30 1981-09-01 Lichtenstein Eric Stefan Systeme de soins medicaux controles par ordinateur.
EP0032927A4 (fr) * 1979-07-31 1982-05-10 Univ Rockefeller Systeme de liberation controlee de substances biologiquement actives dans un fluide d'un corps.
US4469681A (en) * 1979-07-31 1984-09-04 The Rockefeller University Method and system for the controlled release of biologically active substances to a body fluid
FR2557445A1 (fr) * 1984-01-02 1985-07-05 Katsch G Zent Inst Diabetes Procede et dispositif pour la determination automatique prospective de parametres individuellement specifiques de la regulation du glucose
WO1987003814A1 (fr) * 1985-12-20 1987-07-02 Schrezenmeir Juergen Dispositif d'administration continue ou discontinue d'insuline dans le corps humain

Also Published As

Publication number Publication date
JPS51125993A (en) 1976-11-02
IT1053386B (it) 1981-08-31
DE2601893A1 (de) 1976-07-29
SE7600588L (sv) 1976-07-23
AU1032476A (en) 1977-07-21
GB1498332A (en) 1978-01-18
CA1040271A (fr) 1978-10-10

Similar Documents

Publication Publication Date Title
FR2298832A1 (fr) Procede de regulation de
FR2301555A1 (fr) Procede de r
FR2298596A1 (fr) Procede de fa
FR2301613A1 (fr) Procede
FR2312113A1 (fr) Procede de decapage
FR2301288A1 (fr) Procede p
FR2300291A1 (fr) Procede de re
FR2300048A1 (fr) Procede
FR2337120A1 (fr) Procede d
FR2307833A1 (fr) Procede de preparation de polyphenylene-ethers
FR2300812A1 (fr) Procede
FR2299074A1 (fr) Procede
FR2301493A1 (fr) Procede
FR2304601A1 (fr) Procede d'ammonoxydation
FR2299421A1 (fr) Procede de fonctio
FR2297709A1 (fr) Procede de prepara
BE839550A (fr) Procede integre
FR2301966A1 (fr) Procede
FR2302333A1 (fr) Procede de convers
FR2311390A1 (fr) Procede de traiteme
FR2301803A1 (fr) Procede e
FR2300152A1 (fr) Procede
FR2297921A1 (fr) Procede de r
FR2327987A1 (fr) Procede de preparation de 4-alkyl-thiosemicarbazides
FR2300092A1 (fr) Procede

Legal Events

Date Code Title Description
ST Notification of lapse